In another clinical trial, the mutated genes on ctDNA in patients with advanced CRC were found to be APC, TP53, KRAS, and PI3KCA in 73, 72, 66, and 23% of ctDNA samples, respectively (20). Here, KRAS is linked to colorectal carcinoma.